News
FDA completes proceedings against Shah Rukh Khan, Ajay Devgn, Tiger Shroff over Vimal ads
Summary by The Mumbai Editorial Desk TOI City Desk , as published by Times of India — Mumbai
· October 30, 2026
· 1 min read
Photo: Times of India — Mumbai · view original
In a significant development, the Maharashtra Food and Drug Administration has finalized its investigation into prominent actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their endorsements for Vimal Pan Masala, which were deemed violations linked to banned substances. Ajay Devgn is...
Sources and story details Story provenance No corrections
Summary created by The Mumbai Editorial Desk — automated, rule-governed Byline on source page TOI City Desk, as published by Times of India — Mumbai Original story Read at the source Source published Oct 30, 2026 Indexed here Oct 30, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key points Ajay Devgn is now seeking intervention from the Bombay high court on this matter, while the FDA has mandated the actors to explain their promotional roles and cease their campaigns. More News Today’s briefing Local events
Frequently asked about this story
What is this story about? In a significant development, the Maharashtra Food and Drug Administration has finalized its investigation into prominent actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding their endorsements for Vimal Pan Masala, which were deemed violations linked to banned substances. Ajay Devgn is...
When was this published? This article was first published on October 30, 2026 by Times of India — Mumbai and curated for The Mumbai readers.
Who reported this story? This story was reported by TOI City Desk at Times of India — Mumbai. To learn more about how The Mumbai selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The Mumbai, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
